What is it about?
Zika virus is a significant health concern, and there are currently no specific treatments or approved vaccines for it. Resveratrol, a natural compound known for its antiviral properties, has been shown to fight Zika virus, but how it works wasn't clear. This study looked into how a protein called HMGB1 is involved in resveratrol's effect against Zika virus. Researchers treated Zika-infected cells with resveratrol and found that it significantly reduced the amount of virus by over 90%. They discovered that resveratrol helps keep the HMGB1 protein inside the cell nucleus. This is important because it triggers the body's immune response to fight the virus. When they used cells without HMGB1, the virus levels increased significantly. Resveratrol treatment in these cells was less effective, showing that HMGB1 is crucial for resveratrol's antiviral action. The study concluded that resveratrol helps the body produce important immune responses, making it a promising treatment against Zika virus by ensuring HMGB1 stays in the nucleus.
Featured Image
Photo by Amos Bar-Zeev on Unsplash
Why is it important?
The research explores the antiviral properties of Resveratrol (RESV) against Zika virus (ZIKV) infection, shedding light on the mechanisms involved in inhibiting ZIKV replication. The key findings emphasize that RESV treatment leads to the inhibition of ZIKV replication, prevents HMGB1 nucleocytoplasmic translocation, and reduces inflammatory responses in infected cells. Moreover, it suggests that RESV's antiviral effects against ZIKV are likely mediated by HMGB1 nuclear retention, leading to the induction of Interferon (IFN) and activation of Interferon-stimulated Genes (ISG). This study not only highlights RESV as a potential antiviral agent against ZIKV but also underscores the importance of understanding the role of HMGB1 in the therapeutic treatment of Zika virus infection.
Perspectives
This publication stands as a significant contribution to the field, providing a foundation for further investigation into the antiviral properties of Resveratrol and the role of HMGB1 in host responses to ZIKV infection. It sets a valuable precedent for future research efforts in developing effective antiviral strategies against Zika virus and potentially other viral infections.
Kim Ling Chin
University of Malaya
Read the Original
This page is a summary of: Resveratrol Treatment-induced Nuclear HMGB1 Retention is Critical for
Inducing Host Interferon Responses Against Zika Virus, The Natural Products Journal, September 2023, Bentham Science Publishers,
DOI: 10.2174/2210315513666221114112253.
You can read the full text:
Contributors
The following have contributed to this page
